https://www.aexcea.com/japan-patent-office-jpo-issuedd-biomark-patent-with-claims-covering-its-lung-cancer-urine-based-liquid-biopsy-assay/ 2026-09-24T19:37:20+00:00 https://www.aexcea.com/biomark-appoints-kevin-j-cosgriff-to-its-strategic-advisory-team/ 2026-09-24T19:37:19+00:00 https://www.aexcea.com/une-technologie-dici-pour-mieux-diagnostiquer-le-cancer-du-poumon-local-technology-for-improved-lung-cancer-diagnosis/ 2026-09-24T19:37:18+00:00 https://www.aexcea.com/biomark-to-unveil-results-of-its-early-breast-cancer-study-at-the-upcoming-san-antonio-breast-cancer-symposium/ 2026-09-24T19:37:17+00:00 https://www.aexcea.com/biomark-announces-financial-contribution-from-the-city-of-quebec-to-support-commercialization-initiatives-of-its-proprietary-lung-cancer-detection-test/ 2026-09-24T19:37:16+00:00 https://www.aexcea.com/biomark-strengthens-and-expands-its-strategic-advisory-team-in-pursuit-of-commercialization-initiatives/ 2026-09-24T19:37:15+00:00 https://www.aexcea.com/biomark-provides-second-quarter-operational-update-and-announces-extension-to-warrant-exercise-term/ 2026-09-24T19:37:14+00:00 https://www.aexcea.com/biomark-announces-recent-new-patent-granted-in-canada-to-support-its-liquid-biopsy-based-legacy-assay/ 2026-09-24T19:37:13+00:00 https://www.aexcea.com/insightscare-interview-biomark-diagnostics-inc-innovating-cancer-detection/ 2026-09-24T19:37:12+00:00 https://www.aexcea.com/wp-content/uploads/2024/01/Rashid-A-Bux-CEO-and-Founder-BioMark-Diagnostics-Inc.jpg https://www.aexcea.com/biomark-announces-closing-of-1-9-million-non-brokered-private-placement/ 2026-09-24T19:37:11+00:00 https://www.aexcea.com/theresa-peterson-joins-biomarks-advisory-team/ 2026-09-24T19:37:10+00:00 https://www.aexcea.com/biomark-partners-with-rubix-ls-to-advance-blood-based-cancer-screening-in-underserved-communities/ 2026-09-24T19:37:09+00:00 https://www.aexcea.com/biomark-to-advance-development-of-cancer-treatment-for-glioblastoma/ 2026-09-24T19:37:08+00:00 https://www.aexcea.com/biomark-announces-warrant-extension-and-granting-of-options/ 2026-09-24T19:37:07+00:00 https://www.aexcea.com/the-global-breast-cancer-screening-crisis-how-liquid-biopsies-can-bridge-the-divide/ 2026-09-24T19:37:06+00:00 https://www.aexcea.com/wp-content/uploads/2024/05/a-nurse-holding-a-liquid-biopsy-breast-cancer-sample-in-a-sealed-vial-biomark-diagnostics.jpg https://www.aexcea.com/wp-content/uploads/2023/02/biomark-diagnostics-rashid-ahmen.jpg https://www.aexcea.com/wp-content/uploads/2024/05/scientist-and-lab-technician-study-a-liquid-biopsy-for-breast-cancer-biomark-diagnostics.jpg https://www.aexcea.com/a-day-to-honour-dr-daniel-sitar-fellowship-of-the-society-of-pharmacology-and-therapeutics/ 2026-09-24T19:37:05+00:00 https://www.aexcea.com/wp-content/uploads/2024/07/dr-daniel-sitar.jpg https://www.aexcea.com/biomark-diagnostics-announces-presentation-of-promising-glioblastoma-research-at-2024-gpen-conference/ 2026-09-24T19:37:04+00:00 https://www.aexcea.com/the-u-s-patent-and-trademark-office-grants-biomark-patent-that-expands-its-claims-covering-its-legacy-liquid-biopsy-assay/ 2026-09-24T19:37:03+00:00 https://www.aexcea.com/biomark-diagnostics-to-showcase-innovative-liquid-biopsy-technology-at-h-c-wainwrights-26th-annual-global-investment-conference-in-new-york/ 2026-09-24T19:37:02+00:00 https://www.aexcea.com/biomark-diagnostics-completes-testing-of-over-5400-subjects-as-part-of-a-validation-study-for-early-lung-cancer-detection/ 2026-09-24T19:37:01+00:00 https://www.aexcea.com/biomark-diagnostics-and-principal-investigators-publish-an-important-approach-using-metabolomics-and-ml-to-identify-biomarkers-for-nen/ 2026-09-24T19:37:00+00:00 https://www.aexcea.com/biomark-expands-its-liquid-biopsy-platform-with-two-groundbreaking-publications-in-breast-cancer-detection/ 2026-09-24T19:36:59+00:00 https://www.aexcea.com/biomarks-liquid-biopsy-platform-takes-a-major-step-forward-in-breast-cancer-diagnosiswith-ai-powered-er-status-prediction/ 2026-09-24T19:36:58+00:00 https://www.aexcea.com/cancer-prevention-5-actionable-steps/ 2026-09-24T19:36:57+00:00 https://www.aexcea.com/cancer-is-rising-among-women-early-detection-of-lung-cancer/ 2026-09-24T19:36:56+00:00 https://www.aexcea.com/from-black-plastics-to-biomarkers-how-environmental-causes-of-cancer-can-be-prevented/ 2026-09-24T19:36:55+00:00 https://www.aexcea.com/biomark-diagnostics-underscores-commitment-to-rare-diseaseresearch-on-rare-disease-day-2025/ 2026-09-24T19:36:53+00:00 https://www.aexcea.com/remembering-mia-love-a-trailblazers-legacy-and-biomarks-fight-against-cancer/ 2026-09-24T19:36:52+00:00 https://www.aexcea.com/wp-content/uploads/2025/03/official-congressional-photo-of-mia-love-who-passed-from-glioblastoma-early-cancer-detection-biomark-diagnostics.jpg https://www.aexcea.com/biomark-secures-financing-for-initial-tranche-to-advance-early-detection-oncology-testing-platform/ 2026-09-24T19:36:51+00:00 https://www.aexcea.com/biomark-announces-the-final-closing-of-oversubscribed-private-placement/ 2026-09-24T19:36:50+00:00 https://www.aexcea.com/form-7-monthly-progress-report-march-2025/ 2026-09-24T19:36:49+00:00 https://www.aexcea.com/biomark-diagnostics-announces-uplisting-to-otcqb-venture-market/ 2026-09-24T19:36:48+00:00 https://www.aexcea.com/biomark-diagnostics-announces-landmark-publication-validating-high-specificity-and-accuracy-of-its-early-stage-lung-cancer-test/ 2026-09-24T19:36:47+00:00 https://www.aexcea.com/press-release-biomark-diagnostics-announces-breakthrough-publication-reinforcing-leadership-in-ai-powered-metabolomics-for-oncology/ 2026-09-24T19:36:46+00:00 https://www.aexcea.com/press-release-biomark-diagnostics-highlights-fiscal-year-2025-achievements-and-sets-bold-strategic-milestones-for-2025-2026/ 2026-09-24T19:36:45+00:00 https://www.aexcea.com/press-release-biomark-diagnostics-announces-expansion-of-its-specialty-laboratory-services-in-quebec-to-accommodate-increased-demand-from-international-partnerships/ 2026-09-24T19:36:44+00:00 https://www.aexcea.com/biomark-diagnostics-establishes-african-market-presence-through-strategic-tunisia-healthcare-partnership/ 2026-09-24T19:36:43+00:00 https://www.aexcea.com/biomark-patent-asia-lung-cancer/ 2026-09-24T19:36:42+00:00 https://www.aexcea.com/biomarks-liquid-biopsy-platform-selected-for-holistic-german-lung-cancer-screening-trial/ 2026-09-24T19:36:41+00:00 https://www.aexcea.com/biomark-aligns-with-national-strategy-to-slash-lung-cancer-mortality-with-next-gen-liquid-biopsy/ 2026-09-24T19:36:40+00:00 https://www.aexcea.com/biomark-diagnostics-collaborative-lung-cancer-screening-project-honored-by-adriq-during-the-35th-innovation-awards-gala/ 2026-09-24T19:36:39+00:00 https://www.aexcea.com/biomark-diagnostics-advances-commercialization-strategy-by-initiating-iso-15189-accreditation-program/ 2026-09-24T19:36:38+00:00 https://www.aexcea.com/biomark-2025-achievements-2026-vision/ 2026-09-24T19:36:37+00:00 https://www.aexcea.com/biomark-diagnostics-announces-appointment-of-mr-james-lavender-to-board-of-directors/ 2026-09-24T19:36:36+00:00 https://www.aexcea.com/biomark-diagnostics-announces-publication-of-peer-reviewed-validation-of-machine-learning-models-for-lung-cancer-detection-in-frontiers-in-oncology/ 2026-09-24T19:36:35+00:00